Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapies

ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapies

US Patent 11939397 · Granted Mar 26, 2024

Estimated economic value: $61,256,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hybrid optical parametrically-oscillating emitter2025
Natriuretic peptide receptor 1 antibodies and methods of use2025
Anti-CCR7 antibody drug conjugates2024
Anti-CCR7 antibody drug conjugates2024
Anti-CCR7 antibody drug conjugates2024
Alcohol soluble printing ink compositions2024
IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragme2024
Antibody-IL2 engrafted proteins and methods of use in the treatment of cancer2024
Antibody-cytokine engrafted proteins and methods of use for immune related disor2024
mRNA-mediated immunization methods2024
Anti-CCR7 antibody drug conjugates2023
Anti-CCR7 antibody drug conjugates2023